Aktis Oncology director Ken Herrmann disposes of common shares worth $119,256.78 - AKTS News | RalliesAktis Oncology director Ken Herrmann disposes of common shares worth $119,256.78
A
AKTS• Director share sale and option exercises
- Aktis Oncology director Ken Herrmann sold 4,856 shares on July 20, 2026 at $24.56 per share.
- He acquired the same 4,856 shares via option exercises priced at $0.08 and $1.91.
- His directly held common stock position fell to zero following the transactions.
- He reported 18,364 stock options remaining outstanding after the exercises.
ISSC
•
